The workshop will cover a range of key issues, including taxonomy reclassification for the lactobacillus genus, the need for more information on probiotic supplement product labels, establishing an adequate intake for dietary microbes, FDA perspectives and DSHEA, IPA’s new Technology and Standards Committee, and a lawyer’s perspective on the industry.
“A must-attend event”
The fourth IPA DC workshop in collaboration with the US Pharmacopeia will take place on Thursday, October 31 in Bethesda, MD, and brings together key industry stakeholders and federal regulators.
George Paraskevakos, IPA’s executive director, will open the event with IPA’s perspective on the probiotic market. He said the workshop will provide information specific to this unique category that has little overlap with other
“I’ve always professed that probiotics are unique in every way; from manufacturing processes, IP and ownership, to analytical requirements, nomenclature, and safety considerations. As our industry continues to grow IPA’s responsibility as the Global Voice of Probiotics becomes that much more relevant. It is through events such as our workshops that we continue to disseminate the message of probiotic benefits and reinforce our mission of promoting safe and efficacious probiotics globally. Our workshop in DC always highlighted the hottest topics touching our industry and this year certainly will not disappoint,” Paraskevakos said.
According to the event website: “Due to the rapid evolution of the probiotic industry in the past few years, there are a surprising number of topics that have or will substantially affect the global regulatory landscape in the very near future. Topics that every company with a stake in the probiotic sector should be aware of.”
For more information and to register, please click HERE.
Click on the following link to read our coverage of the 2018 workshop: 20 things we learned at the 2018 IPA DC Workshop
Program highlights include:
- More Information Needed on Probiotic Supplement Product Labels: Dr Dan Merenstein, Georgetown University
- The Evolutionary Ecology of Microbial Colonization of the gut - Implications for probiotics: Dr Joe Alcock, University of New Mexico
- A Degree Built by the Industry, for the Industry: Dr Gena Kadar, Southwest College of Naturopathic Medicine
- Establishing an Adequate Intake for Dietary Microbes: Outcomes from an ISAPP Discussion Group: Dr Mary Ellen Sanders, Dairy & Food Culture Technologies
- FDA Perspectives and DSHEA: Steven Tave, Office of Dietary Supplement Programs, FDA/CFSAN
- Probiotic identification and how regulators grade probiotic evidence: Multiple speakers
- FTC hot topics and law enforcement trends in the health product industry: Carolyn Hann, FTC’s Bureau of Consumer Protection, Division of Advertising Practices
- Taxonomy Reclassification-the blue-sky outcome: Prof Michael Ganzle, University of Alberta
- Probiotic Monograph – Challenges and Nomenclature, a regulator’s perspective: Michael Steller, Health Canada
- Lawyer Perspective and Commercial Implications: Ivan Wasserman, Amin Talati Wasserman, and Nina Vinot, Probiotical